Translate Bio: Sanofi completes acquisition of Translate Bio, accelerating the application of mRNA in new vaccines and therapeutics

PARIS - September 14, 2021 - Sanofi announced today the completion of its acquisition of Translate Bio, further accelerating the company's efforts to develop transformative vaccines and therapies using mRNA technology. The acquisition adds a critical pillar to the company's mRNA Center of Excellence which aims to unlock the potential of next-generation mRNA vaccines and other strategic areas such as immunology, oncology, and rare diseases. The tender offer for all of...